ONEMEDNET CORPORATION (ONMD) ROI
- 2025-03-31: ROI 83.48%.
- 2024-12-31: ROI 89.54%.
- 2024-09-30: ROI 106.17%.
- 2023-12-31: ROI 269.98%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2025-03-31
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2025-03-31 | 83.48% |
| 2024-12-31 | 89.54% |
| 2024-09-30 | 106.17% |
| 2023-12-31 | 269.98% |
Annual ROI
| Date | ROI |
|---|---|
| 2024-12-31 | 89.54% |
| 2023-12-31 | 269.98% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |